Notice of republication
This article was republished on December 11, 2020, to correct errors in the Qualitative interviews subsection of the Results section that were introduced during the typesetting process. The publisher apologizes for the errors. Please download this article again to view the correct version. The originally published, uncorrected article and the republished, corrected articles are provided here for reference.
Supporting information
S1 File. Originally published, uncorrected article.
(PDF)
Click here for additional data file. (527.6KB, pdf)
S2 File. Republished, corrected article.
(PDF)
Click here for additional data file. (521.4KB, pdf)
Reference
- 1.Price JT, Mabula-Bwalya CM, Freeman BL, Carda-Auten J, Phiri WM, Chibwe K, et al. (2020) Acceptability of a trial of vaginal progesterone for the prevention of preterm birth among HIV-infected women in Lusaka, Zambia: A mixed methods study. PLoS ONE 15(9): e0238748 10.1371/journal.pone.0238748 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
S1 File. Originally published, uncorrected article.
(PDF)
Click here for additional data file. (527.6KB, pdf)
S2 File. Republished, corrected article.
(PDF)
Click here for additional data file. (521.4KB, pdf)